Liposomal Delivery of Purified Inhibitory-κBα Inhibits Tumor Necrosis Factor-α–Induced Human Vascular Smooth Muscle Proliferation

Vessel injury results in the elaboration of various cytokines, including tumor necrosis factor-alpha (TNF-alpha), which may influence vascular smooth muscle cell (VSMC) function and contribute to atherogenesis. We tested the hypothesis that TNF-alpha-induced VSMC proliferation requires activation of the transcription factor nuclear factor-kappaB (NF-kappaB), which could be prevented by delivery of the NF-kappaB inhibitory peptide, IkappaBalpha. TNF-alpha induced concentration-dependent human VSMC proliferation, and neutralizing antibody to interleukin-6 reduced TNF-alpha-induced VSMC proliferation by 65%. In TNF-alpha-stimulated VSMCs, there was a 3-fold increase in NF-kappaB-dependent luciferase reporter activity that was associated with degradation of IkappaBalpha. To determine an essential role for NF-kappaB in TNF-alpha-induced VSMC proliferation, recombinant IkappaBalpha was introduced into VSMCs via liposomal delivery. Under these conditions, TNF-alpha-induced NF-kappaB nuclear translocation and DNA binding were inhibited, NF-kappaB-dependent luciferase activity was reduced by 50%, there was no degradation of native IkappaBalpha detected, interleukin-6 production was reduced by 54%, and VSMC proliferation was decreased by 60%. In conclusion, the mitogenic effect of TNF-alpha on human arterial VSMCs is dependent on NF-kappaB activation and may be prevented by exogenously delivered IkappaBalpha. Furthermore, liposomal delivery of endogenous inhibitory proteins may represent a novel, therapeutically accessible method for selective transcriptional suppression in the response to vascular injury.

[1]  A. Harken,et al.  Increased levels of myocardial IκB-α protein promote tolerance to endotoxin. , 1998, American journal of physiology. Heart and circulatory physiology.

[2]  R. McIntyre,et al.  Interleukin-10 inhibits human vascular smooth muscle proliferation. , 1998, Journal of molecular and cellular cardiology.

[3]  M. Lindsay,et al.  IκBα Degradation and Nuclear Factor-κB DNA Binding Are Insufficient for Interleukin-1β and Tumor Necrosis Factor-α-induced κB-dependent Transcription* , 1998, The Journal of Biological Chemistry.

[4]  M. Su,et al.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. , 1998, The Journal of clinical investigation.

[5]  P. Libby,et al.  The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[6]  K. Schrör,et al.  Activation of NFκB Is Essential but Not Sufficient to Stimulate Mitogenesis of Vascular Smooth Muscle Cells , 1997 .

[7]  R. Medford,et al.  E-selectin gene expression in vascular smooth muscle cells. Evidence for a tissue-specific repressor protein. , 1997, Circulation research.

[8]  S. Jovinge,et al.  Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[9]  JanNilsson,et al.  Tumor Necrosis Factor-α Activates Smooth Muscle Cell Migration in Culture and Is Expressed in the Balloon-Injured Rat Aorta , 1997 .

[10]  S. Casscells,et al.  Liposomal induction of NO synthase expression in cultured vascular smooth muscle cells. , 1997, Biochemical and biophysical research communications.

[11]  D. Wallach,et al.  MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.

[12]  D. Thomas,et al.  Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. , 1997, Journal of cell science.

[13]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[14]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.

[15]  J. Hiscott,et al.  Biological and biochemical inhibitors of the NF-κB/Rel proteins and cytokine synthesis , 1996 .

[16]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[17]  G. Sonenshein,et al.  Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. , 1995, The Journal of clinical investigation.

[18]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[19]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[20]  D. Kelleher,et al.  Cellular Proliferation and Activation of NFκB Are Induced by Autocrine Production of Tumor Necrosis Factor α in the Human T Lymphoma Line HuT 78 (*) , 1995, The Journal of Biological Chemistry.

[21]  U. Siebenlist,et al.  Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Sonenshein,et al.  Vascular smooth muscle cells express a constitutive NF-kappa B-like activity. , 1994, The Journal of biological chemistry.

[23]  B. Aggarwal,et al.  Effect of tumor necrosis factors, interferons, interleukins, and growth factors on the activation of NF-kappa B: evidence for lack of correlation with cell proliferation. , 1994, Lymphokine and cytokine research.

[24]  R. Kolesnick,et al.  Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. , 1993, The Journal of biological chemistry.

[25]  M. Ferguson,et al.  Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. , 1993, Circulation research.

[26]  W C Greene,et al.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.

[27]  N. Welsh,et al.  Liposomal Delivery of Purified Heat Shock Protein hsp70 Into Rat Pancreatic Islets as Protection Against Interleukin 1β–Induced Impaired β-Cell Function , 1991, Diabetes.

[28]  J. G. Cory,et al.  Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. , 1991, Cancer communications.

[29]  U. Zabel,et al.  Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA , 1990, Cell.

[30]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.

[31]  L. Jonasson,et al.  Immunologic control of vascular cell growth in arterial response to injury and atherosclerosis. , 1989, Transplantation proceedings.

[32]  K. Miyazono,et al.  Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin , 1989, Journal of cellular physiology.

[33]  P. Libby,et al.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. , 1989, Journal of immunology.

[34]  Richard,et al.  Tumor Necrosis Factor Activation of the Sphingomyelin Pathway Signals Nuclear Factor KB Translocation in Intact HL-60 Cells* , 2001 .

[35]  M. Lindsay,et al.  I k B a Degradation and Nuclear Factor- k B DNA Binding Are Insufficient for Interleukin-1 b and Tumor Necrosis Factor- a -induced k B-dependent Transcription* REQUIREMENT FOR AN ADDITIONAL ACTIVATION PATHWAY , 1998 .

[36]  Ronald T. Hay,et al.  Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm , 1997 .

[37]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[38]  P. Libby,et al.  Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β , 1996 .

[39]  J. Isner,et al.  Liposome-mediated gene transfer into human vascular smooth muscle cells. , 1994, Circulation.

[40]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[41]  U. Sieben,et al.  STRUCTURE, REGULATION AND FUNCTION OF NF-1d3 , 1994 .

[42]  N. Morisaki,et al.  Tumour necrosis factor-a can modulate the phenotype of aortic smooth muscle cells , 1993 .

[43]  T. Ogihara,et al.  Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. , 1990, Biochemistry international.